• No results found

[PDF] Top 20 Gadd45a levels in human breast cancer are hormone receptor dependent

Has 10000 "Gadd45a levels in human breast cancer are hormone receptor dependent" found on our website. Below are the top 20 most common "Gadd45a levels in human breast cancer are hormone receptor dependent".

Gadd45a levels in human breast cancer are hormone receptor dependent

Gadd45a levels in human breast cancer are hormone receptor dependent

... modulating human breast cancer, thus far there have been no reports on whether the expression of Gadd45a is correlated with any clinicopathological ...of Gadd45a in human ... See full document

6

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

... We constructed a polytomous unconditional logistic regres- sion model for each risk factor variable, and performed case– case and case–control comparisons within the same model. For case–case comparisons, odds ratios ... See full document

13

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women : the ORDET cohort

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women : the ORDET cohort

... high levels of testosterone were primarily associated with increased risk of ER + /PR + and ER + /PR  cancers, as also found by the Nurses Health Study (8) and a cohort study that examined only ER + tumors ...the ... See full document

9

GPR30 as an initiator of tamoxifen resistance in hormone dependent breast cancer

GPR30 as an initiator of tamoxifen resistance in hormone dependent breast cancer

... in human breast cancer tissue are also in- versely correlated [41]; ERα seems to repress EGFR in breast cancer cells ...in breast cancer cells ... See full document

15

Src promotes estrogen dependent estrogen receptor α proteolysis in human breast cancer

Src promotes estrogen dependent estrogen receptor α proteolysis in human breast cancer

... In breast cancer lines, increased Src activity correlated with a shortened ERα t 1/2 ...ERα levels and estrogen-stimulated ERα loss was impaired by Src ...ERα levels in the BT-20 ... See full document

12

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)

... Methods A recent roundtable discussion was convened by The Breast Cancer Therapy Expert Group (BCTEG) to review existing data on this topic and its impact on their current practice. Results Level 1 evidence ... See full document

11

Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer

Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer

... invasive breast carcinomas and their axillary lymph node metastases versus non-metastatic ...expression levels of GHR and NEDD9 proteins in both, epithelial and stromal components of axillary lymph node ... See full document

26

Estrogen receptor corepressors a role in human breast cancer?

Estrogen receptor corepressors a role in human breast cancer?

... et al. 1999). More studies are needed to decipher which, if any, of these phenotypes is associated with BRCA1’s func- tion as an ERα corepressor. Therefore, it will be necessary to perform detailed studies of the mammary ... See full document

20

Endocrine resistance in hormone receptor positive breast

cancer–from mechanism to therapy

Endocrine resistance in hormone receptor positive breast cancer–from mechanism to therapy

... Metabolic and oxidative stress are a few of the other factors affecting endocrine resistance. The mechanisms are elucidated in detail below for each of these factors. Recent publications have demonstrated that ... See full document

33

WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer

WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer

... in breast cancer HR- negative cells might not be fully dependent on HIF activity, and that other transcription factors are potentially ...in breast cancer, respectively, for co-factors ... See full document

31

Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy

Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy

... tumor levels of urokinase-type plasminogen activator/plasminogen activator inhibitor type 1, denotes highly endocrine responsive ...and/or hormone receptor positivity, together with adverse ... See full document

12

Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells

Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells

... in breast cancer tumors, in T47-D cells, and that treatment with the cholesterol synthesis inhibitor RO reduced MPA- induced CD44 induction in these ...suppresses breast and prostate cancer ... See full document

8

Molecular determinants of context-dependent progesterone receptor action in breast cancer

Molecular determinants of context-dependent progesterone receptor action in breast cancer

... with breast cancer, this balanced A:B ratio is often altered, frequently due to apparent loss of PR-B ...of human tumors [9]. Therefore, loss of PR-B, as measured by protein levels in clinical ... See full document

9

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain

... advanced breast cancer are widely dependent on the appropriate targeting of HRs and ...of breast cancer patients as a result of discordance between pri- mary and metastatic tumors ... See full document

11

Management of hormone receptor positive human epidermal receptor 2 negative advanced or metastatic breast cancers

Management of hormone receptor positive human epidermal receptor 2 negative advanced or metastatic breast cancers

... Abstract: Hormone therapy, rather than chemotherapy, is recommended for hormone-receptor positive (HR+), human epidermal receptor 2 negative (HER2−) advanced or metastatic breast ... See full document

10

Hyperactivation of phosphatidylinositol 3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

Hyperactivation of phosphatidylinositol 3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

... 4 human breast cancer cell lines after long-term estrogen deprivation ...ER levels and sensitivity to ...of hormone-independent ...a breast tumor protein signature of PI3K ... See full document

9

Aberrations in translational regulation are associated with poor prognosis in hormone receptor positive breast cancer

Aberrations in translational regulation are associated with poor prognosis in hormone receptor positive breast cancer

... 25. Wu H, Yang JM, Jin S, Zhang H, Hait WN: Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 2006, 66:3015-3023. 26. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, ... See full document

11

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

... this breast cancer ...(CD3+) levels in cases with high IDO1 in tumor, but not in ...high levels of T regulatory cell infiltration, as measured by FOXP3, similar to Soliman et ...negative ... See full document

9

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status

... androgen receptor (AR) expression with tumor progression and disease-free survival (DFS) in breast cancer ...450 breast cancer patients. We found that breast cancers expressing ... See full document

9

Original Article Expression of thyroid hormone responsive spot 14 homolog and thyroid hormone receptor β1 in human breast cancer tissues and its clinical significance

Original Article Expression of thyroid hormone responsive spot 14 homolog and thyroid hormone receptor β1 in human breast cancer tissues and its clinical significance

... thyroid hormone responsive spot 14 homolog (Thrsp) and thyroid hormone receptor β1 (TRβ1) proteins in human breast cancer tissues and adjacent tissues, as well as its ... See full document

8

Show all 10000 documents...